SAB Biotherapeutics, Inc.

NASDAQ:SABS

1.72 (USD) • At close July 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 5.648.8989.17117.24214.03456.5662.4257.77413.0615.0478.33216.61622.40833.2070.66810.2330.85812.61
Short Term Investments 7.2111.86321.22920.08430.0230000000000000
Cash and Short Term Investments 12.8520.76130.40137.32644.05756.5662.4257.77413.0615.0478.33216.61622.40833.2070.66810.2330.85812.61
Net Receivables 0.0210.0550.0970.2250.193000.3640.7635.55712.9429.61311.7868.011017.109020.569
Inventory 000000000000000000
Other Current Assets 3.4252.9772.0392.032.7012.3410.7020.8681.2091.4940.9081.5211.9758.9750.1030.4270.2631.275
Total Current Assets 16.29723.79232.53739.5846.95158.9073.1289.00615.03222.09722.18227.75136.1748.420.77127.7691.12134.455
Non-Current Assets:
Property, Plant & Equipment, Net 21.37419.92120.74621.7922.63124.68424.83726.00227.20628.3429.82430.86931.30330.949026.443022.083
Goodwill 000000000000000000
Intangible Assets 000000000000000000
Goodwill and Intangible Assets 000000000000000000
Long Term Investments 00001.235000000000116.158116.155116.1520
Tax Assets 000000000000000000
Other Non-Current Assets 0.450.4820.5140.5220.5540.350.3710.4340.4340.4680.5010.535000-116.15500
Total Non-Current Assets 21.82320.40321.2622.31124.4225.03425.20926.43627.6428.80730.32531.40431.30330.949116.15826.443116.15222.083
Total Assets 38.1244.19553.79761.89271.37183.94128.33635.44342.67250.90552.50759.15567.47279.369116.92954.212117.27356.538
Liabilities & Equity:
Current Liabilities:
Account Payables 2.521.6951.2971.1711.240.9461.0831.4041.4453.6795.4844.9444.9814.45905.49807.382
Short Term Debt 1.0770.8120.5251.8081.5132.6551.8581.4581.0951.3962.7332.6452.6261.4901.1601.658
Tax Payables 000000.040.030.020.050.050.0830.0330.1420.2160000
Deferred Revenue 000.1150.1150.3781.3221.6272.8952.93900000.100.100.1
Other Current Liabilities 3.5355.4736.886.0798.4295.854.6125.2358.1369.8688.8028.51610.50618.4190.3223.4380.081.922
Total Current Liabilities 9.6537.988.8167.5528.30510.8139.21111.01113.66614.99317.10116.13718.25624.6840.32210.1970.0811.062
Non-Current Liabilities:
Long Term Debt 5.7063.8573.9964.1313.9384.0543.4524.1194.3654.5334.4254.7565.0885.41605.75706.468
Deferred Revenue Non-Current 000000000000000000
Deferred Tax Liabilities Non-Current 000000000000000000
Other Non-Current Liabilities 1.3536.3894.0834.0896.30611.7740.4170.5960.2380.3210.3581.142.87110.729.7507.8030
Total Non-Current Liabilities 7.05910.2468.0788.2210.24415.8283.874.7154.6044.8534.7835.8967.95816.1369.755.7577.8036.468
Total Liabilities 16.71318.22616.89515.77218.54926.64213.0815.72618.26919.84721.88422.03426.21440.81910.07215.9537.88317.53
Equity:
Preferred Stock 0000000000000000.00200.002
Common Stock 0.0010.0010.0010.0010.0010.0010.0050.0050.0050.0050.0040.0040.0040.004116.150.004104.390.004
Retained Earnings -129.366-124.169-112.774-102.425-95.089-90.064-67.207-62.104-55.224-47.87-39.995-32.919-28.143-29.129-9.294-13.5162.964-11.984
Accumulated Other Comprehensive Income/Loss -0.112-0.1350.052-0.031-0.0630.026000000000000
Other Total Stockholders Equity 150.884150.273149.624148.575147.973147.33682.45781.81679.62178.92370.61470.03669.39767.675051.7692.03550.99
Total Shareholders Equity 21.40725.9736.90346.1252.82257.29915.25619.71624.40331.05830.62337.12141.25838.55106.85738.259109.3939.008
Total Equity 025.9736.90346.1252.82257.29915.25619.71624.40331.05830.62337.12141.25838.55106.85738.259109.3939.008
Total Liabilities & Shareholders Equity 38.1244.19553.79761.89271.37183.94128.33635.44342.67250.90552.50759.15567.47279.369116.92954.212117.27356.538